Intravenous Immune Globulin (IVIG) Treatment Protocol in Kidney Transplant Patients
Status:
Terminated
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the clinical and laboratory observations of IVIG therapy
in the highly sensitized patient. We will study the effects of patients treated with IVIG or
Cytogam in combination with plasmaphoresis to modulate the immune response in highly
sensitized patients. The goal is to convert a positive crossmatch to a compatible crossmatch
that would allow living related transplant to take place or to shorten time on the transplant
waiting list.